drugset

drugset / Trial / NCT07458984

FMT Capsules for rCDI

NCT07458984 ↗

Phase 3 Recruiting 76 enrolled Helsinki University Central Hospital

RandomizedParallel-groupDouble-blindTreatment

Summary

Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.

Timeline

Start: 2026-04-25
Primary completion: 2029-12-31
Completion: 2030-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ornidazole	Other / unclassified	—	Oral

Indications